Evelina Vågesjö
The Power List 2021 – Advanced Medicine
![](/fileadmin/_processed_/6/d/csm_Evelina-Vagesjo-850_d4728eadfc.png)
Co-Founder and Chief Executive Officer at Ilya Pharma
“The development of immunotherapies for oncology has been fantastic. I think the time is now for immunotherapies in other medical indications, steering the different immune cell subtypes to perform whatever tasks are needed – be it reducing fibrosis, increasing regeneration, fighting bacteria more efficiently, regulating blood pressure, or preserving organ function. With ILP-technology, we can use chemokines as therapeutics in a way that works well, is cost efficient, and has scalable manufacturing and a sustainable supply chain, by expressing them from lactic acid bacteria.”
![](/fileadmin/_processed_/b/3/csm_PL_2021_64e44ae125.png)